{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:57:13Z","timestamp":1781643433267,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Daily low-dose aspirin (LDA) is guideline recommended for preeclampsia prevention, but racial\/ethnic disparities persist in its implementation. This systematic review examines disparities in LDA prescription, recommendation and adherence for preeclampsia risk reduction among Black patients compared with other racial\/ethnic groups in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Overall, LDA prescription\/recommendation rates range widely across included studies, from 10.7% to 95% among eligible patients. Black patients are shown to have a similar prescription\/recommendation rate compared to White patients. Adherence rates average around 70%, with Black patients showing lower adherence rates despite similar prescription\/recommendation rates than White patients. Barriers identified included inconsistent counseling, limited access to prenatal care, and distrust of the healthcare system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>While prescribing practices for LDA appear increasingly equitable across racial\/ethnic groups, significant disparities remain in adherence among Black women, potentially contributing to worse maternal outcomes. Reducing these gaps requires culturally tailored patient education, improved physician\u2013patient communication, and systems-level interventions that integrate adherence monitoring into prenatal care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11906-026-01373-8","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:56:17Z","timestamp":1773968177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Aspirin Recommendations for Preeclampsia Risk Reduction: A Systematic Review Focused on Black Patients"],"prefix":"10.1007","volume":"28","author":[{"given":"Yitian","family":"Zha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J","family":"Mikhailov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna H","family":"Brucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Alleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C","family":"Ferdinand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"1373_CR1","doi-asserted-by":"publisher","unstructured":"Hoyert DL. (2025, February 5). Maternal Mortality Rates in the United States, 2023. https:\/\/doi.org\/10.15620\/cdc\/174577","DOI":"10.15620\/cdc\/174577"},{"key":"1373_CR2","unstructured":"Hoyert DL, Mini\u00f1o AM. (2020, January 30). Maternal mortality in the United States: Changes in coding, publication, and data release, 2018. https:\/\/stacks.cdc.gov"},{"key":"1373_CR3","doi-asserted-by":"publisher","unstructured":"Murphy SL, Kochanek KD, Xu J, Arias E. (2024, December 19). Mortality in the United States, 2023. https:\/\/doi.org\/10.15620\/cdc\/170564","DOI":"10.15620\/cdc\/170564"},{"key":"1373_CR4","doi-asserted-by":"publisher","unstructured":"Writing Committee Members, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson,H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A.P., Carter, J., Cohen, J. B., Collins, K. J., Commodore-Mensah, Y., Davis, L. L.,Egan, B., Khan, S. S., Lloyd-Jones, D. M., \u2026 Williamson, J. D. (2025). 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 152(11), e114\u2013e218. https:\/\/doi.org\/10.1161\/CIR.0000000000001356.","DOI":"10.1161\/CIR.0000000000001356."},{"key":"1373_CR5","doi-asserted-by":"publisher","unstructured":": Gestational Hypertension and Preeclampsia, Bulletin ACOGP. Number 222. (2020). Obstetrics & Gynecology, 135(6), e237. https:\/\/doi.org\/10.1097\/AOG.0000000000003891","DOI":"10.1097\/AOG.0000000000003891"},{"key":"1373_CR6","unstructured":"Khalid F, Mahendraker N, Tonismae T. (2025). HELLP Syndrome. In StatPearls. StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560615\/"},{"key":"1373_CR7","unstructured":"Magley M, Hinson MR. (2025). Eclampsia. In StatPearls. StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554392\/"},{"key":"1373_CR8","doi-asserted-by":"publisher","unstructured":"Beckett AG, McFadden MD, Warrington JP. Preeclampsia history and postpartum risk of cerebrovascular disease and cognitive impairment: Potential mechanisms. Front Physiol. 2023;14. https:\/\/doi.org\/10.3389\/fphys.2023.1141002.","DOI":"10.3389\/fphys.2023.1141002"},{"issue":"11","key":"1373_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M14-1884","volume":"161","author":"ML LeFevre","year":"2014","unstructured":"LeFevre ML, on behalf of the U.S. Preventive Services Task Force. Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;161(11):819\u201326. https:\/\/doi.org\/10.7326\/M14-1884.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1373_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"US Preventive Services Task Force","year":"2021","unstructured":"US Preventive Services Task Force. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;326(12):1186\u201391. https:\/\/doi.org\/10.1001\/jama.2021.14781.","journal-title":"JAMA"},{"key":"1373_CR11","unstructured":"Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality. (n.d.). Retrieved November 20, 2025, from https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/12\/low-dose-aspirin-use-for-the-prevention-of-preeclampsia-and-related-morbidity-and-mortality"},{"key":"1373_CR12","unstructured":"Preeclampsia., Genomics and Public Health | Blogs | CDC. (2022, October 25). https:\/\/blogs.cdc.gov\/genomics\/2022\/10\/25\/preeclampsia\/"},{"issue":"7","key":"1373_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jama.2021.13304","volume":"326","author":"A Flanagin","year":"2021","unstructured":"Flanagin A, Frey T, Christiansen SL, AMA Manual of Style Committee. Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals. JAMA. 2021;326(7):621\u20137. https:\/\/doi.org\/10.1001\/jama.2021.13304.","journal-title":"JAMA"},{"key":"1373_CR14","doi-asserted-by":"publisher","unstructured":"Oremus, M., Oremus, C., Hall, G. B. C., McKinnon, M. C., ECT &, & Team, C. S.R. (2012). Inter-rater and test\u2013retest reliability of quality assessments by novice student raters using the Jadad and Newcastle\u2013Ottawa Scales. BMJ Open, 2(4), e001368. https:\/\/doi.org\/10.1136\/bmjopen-2012-001368.","DOI":"10.1136\/bmjopen-2012-001368."},{"key":"1373_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preghy.2023.09.002","volume":"34","author":"M Ayyash","year":"2023","unstructured":"Ayyash M, Goyert G, Pitts D, Khangura R, Garcia R, Jacobsen G, Shaman M. Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia. Pregnancy Hypertens. 2023;34:1\u20134. https:\/\/doi.org\/10.1016\/j.preghy.2023.09.002.","journal-title":"Pregnancy Hypertens"},{"issue":"06","key":"1373_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1055\/s-0040-1718580","volume":"38","author":"RC Boelig","year":"2021","unstructured":"Boelig RC, Wanees M, Zhan T, Berghella V, Roman A. Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study. Am J Perinatol. 2021;38(06):544\u201352. https:\/\/doi.org\/10.1055\/s-0040-1718580.","journal-title":"Am J Perinatol"},{"issue":"1","key":"1373_CR17","doi-asserted-by":"publisher","first-page":"S465","DOI":"10.1016\/j.ajog.2019.11.749","volume":"222","author":"J Abbott","year":"2020","unstructured":"Abbott J, Mendez L, Miller E, Noel N, Francoeur A, Karzhevsky S, Wang C, Vragovic O. 735: Provision of prenatal aspirin in an urban safety-net population improves equity in perinatal hypertensive outcomes. Am J Obstet Gynecol. 2020;222(1):S465. https:\/\/doi.org\/10.1016\/j.ajog.2019.11.749.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1373_CR18","doi-asserted-by":"publisher","first-page":"S515","DOI":"10.1016\/j.ajog.2021.11.850","volume":"226","author":"MS Wong","year":"2022","unstructured":"Wong MS, Parrinella K, Wells M, Gregory KD. Black pregnant people are less likely to be recommended aspirin prophylaxis for preeclampsia. Am J Obstet Gynecol. 2022;226(1):S515\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2021.11.850.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1373_CR19","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1016\/j.ajog.2023.11.476","volume":"230","author":"TS Freret","year":"2024","unstructured":"Freret TS, Mantha AB, James KE, Kaimal AJ, Melamed A, Clapp MA. 450 Changes in low-dose aspirin use after updated USPSTF and ACOG guidance on race. Am J Obstet Gynecol. 2024;230(1):S247\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2023.11.476.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1373_CR20","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1016\/j.ajog.2022.11.522","volume":"228","author":"EN Teal","year":"2023","unstructured":"Teal EN. Racial\/ethnic differences in low-dose aspirin use for preeclampsia risk reduction. Am J Obstet Gynecol. 2023;228(1):S294\u20135. https:\/\/doi.org\/10.1016\/j.ajog.2022.11.522.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1373_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s12884-023-06039-w","volume":"23","author":"N Singh","year":"2023","unstructured":"Singh N, Shuman S, Chiofalo J, Cabrera M, Smith A. Missed opportunities in aspirin prescribing for preeclampsia prevention. BMC Pregnancy Childbirth. 2023;23(1):717. https:\/\/doi.org\/10.1186\/s12884-023-06039-w.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1373_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17161\/kjm.vol16.18138","volume":"16","author":"B Campo","year":"2023","unstructured":"Campo B, Fogel J, Na S, Bryson L. Impact of Aspirin Supplementation for Pre-Eclampsia Prevention on Neonatal Outcomes. Kans J Med. 2023;16(1):41\u20137. https:\/\/doi.org\/10.17161\/kjm.vol16.18138.","journal-title":"Kans J Med"},{"issue":"05","key":"1373_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1055\/s-0042-1743142","volume":"41","author":"NW Ragunanthan","year":"2024","unstructured":"Ragunanthan NW, Lamb J, Hauspurg A, Beck S. Assessment of Racial Disparities in Aspirin Prophylaxis for Preeclampsia Prevention. Am J Perinatol. 2024;41(05):635\u201340. https:\/\/doi.org\/10.1055\/s-0042-1743142.","journal-title":"Am J Perinatol"},{"issue":"1","key":"1373_CR24","doi-asserted-by":"publisher","first-page":"S699","DOI":"10.1016\/j.ajog.2022.11.1171","volume":"228","author":"MS Wong","year":"2023","unstructured":"Wong MS, Torna S, Wells M, Gregory KD. Automated clinical decision support eliminates racial disparities in aspirin recommendation. Am J Obstet Gynecol. 2023;228(1):S699\u2013700. https:\/\/doi.org\/10.1016\/j.ajog.2022.11.1171.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1373_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12884-023-05922-w","volume":"23","author":"ME Gross","year":"2023","unstructured":"Gross ME, Godecker A, Hughes A, Sampene K. Leveraging quality improvement to promote health equity: Standardization of prenatal aspirin recommendations. BMC Pregnancy Childbirth. 2023;23(1):651. https:\/\/doi.org\/10.1186\/s12884-023-05922-w.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1373_CR26","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1016\/j.ajog.2021.11.562","volume":"226","author":"S Myers","year":"2022","unstructured":"Myers S, Luke S, Collier KR, Truong T, Weaver K, Swamy GK, Wheeler SM. Low Dose Aspirin Counseling in Nulliparous Women. Am J Obstet Gynecol. 2022;226(1):S335. https:\/\/doi.org\/10.1016\/j.ajog.2021.11.562.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1373_CR27","doi-asserted-by":"publisher","first-page":"S286","DOI":"10.1016\/j.ajog.2023.11.552","volume":"230","author":"O Mesina","year":"2024","unstructured":"Mesina O, Applegarth C, Buckner E, Ruppin A, Pinson K, Tarsa M. 527 Differences in LDASA initiation for preeclampsia prevention in at-risk pregnancies between White and non-White patients. Am J Obstet Gynecol. 2024;230(1):S286\u20137. https:\/\/doi.org\/10.1016\/j.ajog.2023.11.552.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1373_CR28","doi-asserted-by":"publisher","first-page":"S469","DOI":"10.1016\/j.ajog.2019.11.755","volume":"222","author":"NW Ragunanthan","year":"2020","unstructured":"Ragunanthan NW, Lamb JE, Hauspurg A, Beck S. 741: Assessment of racial disparities in aspirin prophylaxis for preeclampsia prevention. Am J Obstet Gynecol. 2020;222(1):S469. https:\/\/doi.org\/10.1016\/j.ajog.2019.11.755.","journal-title":"Am J Obstet Gynecol"},{"key":"1373_CR29","doi-asserted-by":"publisher","first-page":"36S","DOI":"10.1097\/01.AOG.0000663332.12839.a1","volume":"135","author":"J Lauring","year":"2020","unstructured":"Lauring J, Flores ES, Brewster H. Racial\/Ethnic Parity in Low-Dose Aspirin for Women With History of Preeclampsia After National Recommendations [26\u00a0C]. Obstet Gynecol. 2020;135:36S. https:\/\/doi.org\/10.1097\/01.AOG.0000663332.12839.a1.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1373_CR30","doi-asserted-by":"publisher","first-page":"e0302720","DOI":"10.1371\/journal.pone.0302720","volume":"19","author":"R Vinogradov","year":"2024","unstructured":"Vinogradov R, Holden E, Patel M, Grigg R, Errington L, Ara\u00fajo-Soares V, Rankin J. Barriers and facilitators of adherence to low-dose aspirin during pregnancy: A co-produced systematic review and COM-B framework synthesis of qualitative evidence. PLoS ONE. 2024;19(5):e0302720. https:\/\/doi.org\/10.1371\/journal.pone.0302720.","journal-title":"PLoS ONE"},{"issue":"2","key":"1373_CR31","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.039","volume":"229","author":"CA Combs","year":"2023","unstructured":"Combs CA, Kumar NR, Morgan JL. Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention\u2014quality metric and opportunities for quality improvement. Am J Obstet Gynecol. 2023;229(2):B2\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2023.04.039.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"1373_CR32","doi-asserted-by":"publisher","first-page":"e2325803","DOI":"10.1001\/jamanetworkopen.2023.25803","volume":"6","author":"GC Cloud","year":"2023","unstructured":"Cloud GC, Williamson JD, Thao LTP, Tran C, Eaton CB, Wolfe R, Nelson MR, Reid CM, Newman AB, Lockery J, Fitzgerald SM, Murray AM, Shah RC, Woods RL, Donnan GA, McNeil JJ. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023;6(7):e2325803. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.25803.","journal-title":"JAMA Netw Open"},{"key":"1373_CR33","unstructured":"WHO statement on autism-related issues. (n.d.). Retrieved November 20, 2025, from https:\/\/www.who.int\/news\/item\/24-09-2025-who-statement-on-autism-related-issues"},{"key":"1373_CR34","unstructured":"Commissioner O of the. (2025, September 22). FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy. FDA; FDA. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-responds-evidence-possible-association-between-autism-and-acetaminophen-use-during-pregnancy"},{"issue":"11","key":"1373_CR35","doi-asserted-by":"publisher","first-page":"101768","DOI":"10.1016\/j.ajogmf.2025.101768","volume":"7","author":"MJ Rodriguez-Sibaja","year":"2025","unstructured":"Rodriguez-Sibaja MJ, Galvez-Rubalcava N, Hagerman-Sucar G, Alcocer-Gonzalez Camarena P, Gomez-Woodworth JR, Villalpando-Juarez MI, Acevedo-Gallegos S, Velazquez-Torres B, Ramirez-Calvo JA, Copado-Mendoza DY, Lumbreras-Marquez MI. Maternal, fetal, and neonatal serious adverse events associated with low-dose aspirin during the first trimester of pregnancy: A secondary analysis of the Aspirin Supplmentation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) trial. Am J Obstet Gynecol MFM. 2025;7(11):101768. https:\/\/doi.org\/10.1016\/j.ajogmf.2025.101768.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"7","key":"1373_CR36","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jama.2023.0691","volume":"329","author":"M Mendoza","year":"2023","unstructured":"Mendoza M, Bonacina E, Garcia-Manau P, L\u00f3pez M, Caami\u00f1a S, Vives \u00c0, Lopez-Quesada E, Ricart M, Maroto A, de Mingo L, Pintado E, Ferrer-Costa R, Martin L, Rodr\u00edguez-Zurita A, Garcia A, Pallarols M, Vidal-Sagnier L, Teixidor M, Orizales-Lago C, Suy A. Aspirin Discontinuation at 24 to 28 Weeks\u2019 Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial. JAMA. 2023;329(7):542\u201350. https:\/\/doi.org\/10.1001\/jama.2023.0691.","journal-title":"JAMA"},{"issue":"15","key":"1373_CR37","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1161\/CIR.0000000000001000","volume":"144","author":"LS Mehta","year":"2021","unstructured":"Mehta LS, Sharma G, Creanga AA, Hameed AB, Hollier LM, Johnson JC, Leffert L, McCullough LD, Mujahid MS, Watson K, White CJ, on behalf of the American Heart Association Advocacy Coordinating Committee. Call to Action: Maternal Health and Saving Mothers: A Policy Statement From the American Heart Association. Circulation. 2021;144(15):e251\u201369. https:\/\/doi.org\/10.1161\/CIR.0000000000001000.","journal-title":"Circulation"},{"key":"1373_CR38","doi-asserted-by":"publisher","first-page":"e917","DOI":"10.1055\/s-0042-1759705","volume":"41","author":"NR Kumar","year":"2024","unstructured":"Kumar NR, Speedy SE, Song J, Welty LJ, Cavens AD. Quality Improvement Initiative for Aspirin Screening and Prescription Rates for Preeclampsia Prevention in an Outpatient Obstetric Clinic. Am J Perinatol. 2024;41:e917\u201321. https:\/\/doi.org\/10.1055\/s-0042-1759705.","journal-title":"Am J Perinatol"},{"issue":"1","key":"1373_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12884-022-05218-5","volume":"23","author":"A Davies","year":"2023","unstructured":"Davies A, Mullin S, Chapman S, Barnard K, Bakhbakhi D, Ion R, Neuberger F, Standing J, Merriel A, Fraser A, Burden C. Interventions to enhance medication adherence in pregnancy- a systematic review. BMC Pregnancy Childbirth. 2023;23(1):135. https:\/\/doi.org\/10.1186\/s12884-022-05218-5.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1373_CR40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41746-025-01966-8","volume":"8","author":"KM Jaeger","year":"2025","unstructured":"Jaeger KM, Nissen M, Leutheuser H, Danzberger N, Titzmann A, Pontones CA, Goossens C, Ziegler P, Uhrig S, Haeberle L, Bleher H, Kast K, Kornhuber J, Schoeffski O, Braun M, Fasching PA, Beckmann MW, Eskofier BM, Huebner H. Adherence to digital pregnancy care \u2013 lessons learned from the SMART start feasibility study. Npj Digit Med. 2025;8(1):561. https:\/\/doi.org\/10.1038\/s41746-025-01966-8.","journal-title":"Npj Digit Med"},{"issue":"2","key":"1373_CR41","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.amepre.2021.08.012","volume":"62","author":"LA Roman","year":"2022","unstructured":"Roman LA, Raffo JE, Strutz KL, Luo Z, Johnson ME, Meulen PV, Henning S, Baker D, Titcombe C, Meghea CI. The Impact of a Population-Based System of Care Intervention on Enhanced Prenatal Care and Service Utilization Among Medicaid-Insured Pregnant Women. Am J Prev Med. 2022;62(2):e117\u201327. https:\/\/doi.org\/10.1016\/j.amepre.2021.08.012.","journal-title":"Am J Prev Med"},{"key":"1373_CR42","doi-asserted-by":"publisher","unstructured":"Pozzo JD, Kouba I, Jackson F, Green J, Demertzis K, Zeeshan Q, Blitz MJ. Implementation of a universal low-dose aspirin protocol for the prevention of preeclampsia in a federally qualified health center. J Perinat Med. n.d. https:\/\/doi.org\/10.1515\/jpm-2025-0215.","DOI":"10.1515\/jpm-2025-0215"},{"issue":"2","key":"1373_CR43","doi-asserted-by":"publisher","first-page":"e069","DOI":"10.1097\/og9.0000000000000069","volume":"2","author":"TS Freret","year":"2025","unstructured":"Freret TS, Bryant AS, James KE, Kaimal AJ, Melamed A, Clapp MA. Changes in Low-Dose Aspirin Use After Updated Guidance on Sociodemographic Risk Factors for Preeclampsia. O&G Open. 2025;2(2):e069. https:\/\/doi.org\/10.1097\/og9.0000000000000069.","journal-title":"O&G Open"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-026-01373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-026-01373-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-026-01373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:31:05Z","timestamp":1781641865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-026-01373-8"}},"subtitle":["Current Hypertension Reports"],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s11906-026-01373-8","relation":{},"ISSN":["1534-3111"],"issn-type":[{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}